Dana Vigier Vice President, Global Commercial Oncology AstraZeneca
Koen Janssens Associate Director Field Force Effectiveness Norgine
Mehrnaz Campbell Founder & CEO Cheemia
Audrey Krassnitzer Global MCE Director Novo Nordisk
Paul Simms Chief Executive Impatient Health
The ‘future of the sales rep’ has been debated many times before. With the arrival of the pandemic and a sudden shift to bits and bytes, many predicted the field-force would become dead as a dodo.
Not true. The future is human. Tech stocks have spent the past year falling to record lows and many are questioning the viability of a world containing only digital campaigns. Both reps and commercial leaders have a powerful role in the future, so long as they are willing to adapt.
And adaptation is the name of the game. Humans can overcome internal silos, make nuanced decisions, communicate scientific information in a compelling way and be a doctor’s best friend. The priority is now much more about enabling the field staff who already have good HCP relations to become tech-savvy, rather than replacing them with data scientists and bots.
With the right upskilling, sales teams can become OX orchestrators, health system negotiators, medical-commercial triage agents and much more. Yes, it is possible to make cuts to the traditional rank-and-file reps, whilst empowering and upgrading those who remain.
Join this webinar to determine the future of commercial teams, and work out where to invest and adapt to conquer tomorrow’s world.